By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose
News

Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose

Jimmie Dempsey
Last updated: June 15, 2025 8:02 pm
Jimmie Dempsey Published June 15, 2025
Share
SHARE

NEWYou can now listen to Fox News articles!

A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk.

The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia.

The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with heart disease or had genetically high cholesterol, according to a university press release. 

THIS CHEAP PANTRY STAPLE COULD BE KEY TO LOWERING CHOLESTEROL, NEW RESEARCH SUGGESTS

All participants were receiving “maximum tolerated doses” of cholesterol-lowering therapy.

One group received Obicetrapib and another group took a placebo, while still maintaining their existing cholesterol drugs. 

After 12 weeks, the participants taking the new drug showed a 32.6% reduction in LDL cholesterol and a 33.5% drop in lipoprotein(a) [Lp(a)], the release stated.

The findings were presented last month at the European Atherosclerosis Society Congress in the U.K. and were also published in The New England Journal of Medicine.

WOMEN’S HEART DISEASE RISK COULD BE PREDICTED UP TO 30 YEARS IN ADVANCE WITH ONE BLOOD TEST, STUDY FINDS

“We know that many people at high risk of heart attack or stroke don’t get their cholesterol levels low enough, even on the best available treatments,” said study lead Professor Stephen Nicholls, director of Monash University’s Victorian Heart Institute and Monash Health’s Victorian Heart Hospital, in the release.

“We know that many people at high risk of heart attack or stroke don’t get their cholesterol levels low enough, even on the best available treatments.”

“Obicetrapib offers a promising new option — not only did it lower LDL cholesterol by over 30%, but we also saw a reduction in Lp(a), which is much harder to treat and has been linked to increased heart disease risk.”

LDL cholesterol

Low-density lipoprotein (LDL), which is sometimes called “bad cholesterol,” is associated with negative health effects when present in high amounts.

LDL can build up in the blood vessels and increase heart attack and stroke risk, the researchers cautioned.

Lipoprotein(a), or Lp(a), is a protein that is known to greatly increase the chances of a heart attack when it’s present in high levels in the blood.

Unlike LDL, Lp(a) is an inherited risk factor that can’t be modified with healthy behaviors or medications.

Man holding chest

Obicetrapib was found to be “well-tolerated” by the participants, the researchers noted. 

“This could be a valuable tool in the fight against heart disease,” Nicholls added. “It’s convenient, it’s effective, and it may help close the gap for patients who’ve run out of options.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The study — which was funded by NewAmsterdam Pharma, a developer of Obicetrapib that is based in the Netherlands — did have some limitations, the researchers noted.

man puts pill in mouth

For example, the participants were not chosen based on high Lp(a), which means the study did not determine how the drug impacted those with elevated levels of the protein.

Additionally, the study assessed changes in LDL levels, but did not measure actual heart attack or stroke outcomes.

For more Health articles, visit www.foxnews.com/health

More studies are needed to follow patients for longer time periods and to include more diverse cohorts, the researchers acknowledged.

Fox News Digital reached out to the researchers for additional comment.

Read the full article here

You Might Also Like

WNBA players rank Caitlin Clark 9th best All-Star guard despite leading fan voting

Freed Israeli hostage says Hamas captors ‘wanted Kamala to be elected,’ were ‘very scared’ of Trump’s return

Gender controversy swirls around Olympic gold medalist after new report sheds light on medical tests

Indiana takes first action in long shot plan to acquire parts of Illinois

ESPN host’s off-color joke during WNBA All-Star broadcast draws mixed reactions from viewers

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
Bears’ Caleb Williams shares powerful message on painted finger nails before season opener vs Vikings
News

Bears’ Caleb Williams shares powerful message on painted finger nails before season opener vs Vikings

Jimmie Dempsey Jimmie Dempsey September 9, 2025
NYC mayoral candidate Zohran Mamdani defends past tweets, says Cuomo attacking ‘mythical version’ of him
Senate GOP leader moves to lower filibuster threshold for Trump nominees through nuclear option
Sam Tran Makes We Knife Co. Debut with the Ryson
Mark Zuckerberg sues Meta over Facebook suspensions — but not the one you think
Hegseth visits Puerto Rico as US boosts Caribbean military operations
Zohran Mamdani’s Price Controls Would be Disastrous for New York City
Prepping & Survival

Zohran Mamdani’s Price Controls Would be Disastrous for New York City

Jimmie Dempsey Jimmie Dempsey September 8, 2025
Cowboys CEO Stephen Jones says Micah Parsons trade is ‘in our rearview mirror’ after his Packers debut
News

Cowboys CEO Stephen Jones says Micah Parsons trade is ‘in our rearview mirror’ after his Packers debut

Jimmie Dempsey Jimmie Dempsey September 8, 2025
Fort Irwin breaks ground on first privatized junior enlisted barracks
Tactical

Fort Irwin breaks ground on first privatized junior enlisted barracks

Jimmie Dempsey Jimmie Dempsey September 8, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Videos
  • Guns and Gear
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?